EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
Open Access
- 1 August 2005
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 18 (8), 1027-1033
- https://doi.org/10.1038/modpathol.3800438
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chromogenic In Situ Hybridization for the Detection of HER-2/neuGene Amplification in Breast Cancer With an Emphasis on Tumors With Borderline and Low-Level AmplificationAmerican Journal of Clinical Pathology, 2005
- Prognostic Relevance of Gene Amplifications and Coamplifications in Breast CancerCancer Research, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- Heregulin Regulation of Akt/Protein Kinase B in Breast Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Genistein, a Tyrosine Kinase Inhibitor, Reduces EGF-Induced EGF Receptor Internalization and Degradation in Human Hepatoma HepG2 CellsBiochemical and Biophysical Research Communications, 1996
- Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature, 1995
- Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neuJournal of Steroid Biochemistry, 1989